Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Evolutionary Relationships through Genome Comparisons02:54

Evolutionary Relationships through Genome Comparisons

7.2K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
7.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gamabufotalin suppresses pancreatic cancer through redox-homeostasis disruption by G6PD downregulation.

Journal of translational medicine·2026
Same author

Squalene in <i>Camellia oleifera</i>: Biosynthetic Pathways, Regulatory Networks, and Functional Perspectives.

Plants (Basel, Switzerland)·2026
Same author

A multicenter, clinically interpretable prediction model for malignancy risk in C-TIRADS 3-4 thyroid nodules.

Frontiers in oncology·2026
Same author

Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026
Same author

CGHNet: Cross-Guided 2D-3D Hybrid Network with attention mechanism for focal liver lesion classification.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society·2026
Same author

FTGID: Fine-Grained Text-Driven Framework for Universal Generative Image Detection.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same journal

Improved prognostic survival models for pediatric medulloblastoma using high dimensional gene expression data.

BMC medical genomics·2026
Same journal

Identification of a novel pathogenic variant in MYLK in an Iranian family with non-syndromic familial aortic aneurysm and dissection by whole-exome sequencing and literature review.

BMC medical genomics·2026
Same journal

Genomic determinants of fluoroquinolone resistance in Escherichia coli in Nigeria: dominance of QRDR mutations and limited contribution of PMQR in a cross-sectional study.

BMC medical genomics·2026
Same journal

Crosstalk mediators implicated in the Stevens-Johnson Syndrome through gene regulatory network analysis.

BMC medical genomics·2026
Same journal

Familial lymphoma and genetic predisposition: an updated review.

BMC medical genomics·2026
Same journal

Discovery and validation of a prognostic SPP1/PLAU signature in HPV-negative oropharyngeal squamous cell carcinoma.

BMC medical genomics·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.5K

A fast and high performance multiple data integration algorithm for identifying human disease genes.

Bolin Chen, Min Li, Jianxin Wang

    BMC Medical Genomics
    |September 25, 2015
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a fast algorithm for identifying human disease genes by integrating multiple data sources. The new method achieves high prediction accuracy and significantly reduces computational time compared to existing approaches.

    More Related Videos

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
    05:53

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

    Published on: June 21, 2018

    10.8K
    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
    11:35

    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

    Published on: August 21, 2016

    13.7K

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
    06:41

    In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

    Published on: August 20, 2019

    14.5K
    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
    05:53

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

    Published on: June 21, 2018

    10.8K
    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
    11:35

    Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

    Published on: August 21, 2016

    13.7K

    Area of Science:

    • Genomics
    • Bioinformatics
    • Computational Biology

    Background:

    • Disease gene identification is crucial for understanding genetic diseases.
    • Integrating multiple data sources improves accuracy due to network proximity and complex gene-disease associations.
    • Existing algorithms for disease gene prediction require performance and speed enhancements.

    Purpose of the Study:

    • To develop a fast and high-performance algorithm for human disease gene identification.
    • To enhance disease gene prediction by integrating multiple biological data sources.
    • To improve upon the predictive accuracy and computational efficiency of current methods.

    Main Methods:

    • A Bayesian analysis method and binary logistic regression model are used to calculate posterior probabilities of gene-disease associations.
    • The algorithm integrates multiple data sources, including biological networks.
    • Two prior probability estimation strategies and two feature vector construction methods were employed.

    Main Results:

    • The proposed algorithm achieves high Area Under the Curve (AUC) scores, indicating strong predictive performance.
    • Using a single PPI network with F2 feature vectors yielded an AUC of 0.769 with an average running time of 1.5 seconds.
    • Integrating three biological networks with F3 feature vectors increased the AUC to 0.830 while maintaining a fast average running time of 12.54 seconds.

    Conclusions:

    • The developed algorithm offers both high prediction accuracy (AUC up to 0.830) and remarkable speed.
    • It outperforms many existing algorithms in terms of both performance and computational efficiency.
    • This approach represents a significant advancement in disease gene identification through data integration.